(19)
(11) EP 2 094 848 A2

(12)

(88) Date of publication A3:
22.05.2008

(43) Date of publication:
02.09.2009 Bulletin 2009/36

(21) Application number: 07842750.7

(22) Date of filing: 19.09.2007
(51) International Patent Classification (IPC): 
C12N 15/11(2006.01)
(86) International application number:
PCT/US2007/078859
(87) International publication number:
WO 2008/036718 (27.03.2008 Gazette 2008/13)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 19.09.2006 US 826173 P
22.05.2007 US 939573 P

(71) Applicant: Asuragen, INC.
Austin, TX 78744 (US)

(72) Inventors:
  • BADER, Andreas G.
    Austin, TX 78744 (US)
  • BYROM, Mike
    Austin, TX 78744 (US)
  • JOHNSON, Charles D.
    Austin, TX 78744 (US)
  • BROWN, David
    Austin, TX 78744 (US)

(74) Representative: Sonn & Partner Patentanwälte 
Riemergasse 14
1010 Wien
1010 Wien (AT)

   


(54) MIR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION